These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33537013)

  • 1. Considerations for Phage Therapy Against
    Senhaji-Kacha A; Esteban J; Garcia-Quintanilla M
    Front Microbiol; 2020; 11():609017. PubMed ID: 33537013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
    Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785625
    [No Abstract]   [Full Text] [Related]  

  • 3. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
    Nick JA; Dedrick RM; Gray AL; Vladar EK; Smith BE; Freeman KG; Malcolm KC; Epperson LE; Hasan NA; Hendrix J; Callahan K; Walton K; Vestal B; Wheeler E; Rysavy NM; Poch K; Caceres S; Lovell VK; Hisert KB; de Moura VC; Chatterjee D; De P; Weakly N; Martiniano SL; Lynch DA; Daley CL; Strong M; Jia F; Hatfull GF; Davidson RM
    Cell; 2022 May; 185(11):1860-1874.e12. PubMed ID: 35568033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Dedrick RM; Smith BE; Cristinziano M; Freeman KG; Jacobs-Sera D; Belessis Y; Whitney Brown A; Cohen KA; Davidson RM; van Duin D; Gainey A; Garcia CB; Robert George CR; Haidar G; Ip W; Iredell J; Khatami A; Little JS; Malmivaara K; McMullan BJ; Michalik DE; Moscatelli A; Nick JA; Tupayachi Ortiz MG; Polenakovik HM; Robinson PD; Skurnik M; Solomon DA; Soothill J; Spencer H; Wark P; Worth A; Schooley RT; Benson CA; Hatfull GF
    Clin Infect Dis; 2023 Jan; 76(1):103-112. PubMed ID: 35676823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes.
    Hashemi Shahraki A; Mirsaeidi M
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33799414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage infection and killing of intracellular
    Schmalstig AA; Wiggins A; Badillo D; Wetzel KS; Hatfull GF; Braunstein M
    mBio; 2024 Jan; 15(1):e0292423. PubMed ID: 38059609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Phage-Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in
    Gorzynski M; De Ville K; Week T; Jaramillo T; Danelishvili L
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus.
    Johansen MD; Alcaraz M; Dedrick RM; Roquet-Banères F; Hamela C; Hatfull GF; Kremer L
    Dis Model Mech; 2021 Sep; 14(9):. PubMed ID: 34530447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities.
    Hatfull GF
    Pulm Ther; 2023 Mar; 9(1):91-107. PubMed ID: 36583829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities.
    Amarh ED; Dedrick RM; Garlena RA; Russell DA; Gauthier CH; Aull HG; Abad L; Jacobs-Sera D; Akusobi C; Rubin EJ; Hatfull GF
    PLoS One; 2023; 18(2):e0281769. PubMed ID: 36795728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
    Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phages for the treatment of Mycobacterium species.
    Opperman CJ; Wojno J; Goosen W; Warren R
    Prog Mol Biol Transl Sci; 2023; 201():41-92. PubMed ID: 37770176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacteriophages as Genomic Engineers and Anti-infective Weapons.
    Sullivan MR; Rubin EJ; Dulberger CL
    mBio; 2021 May; 12(3):. PubMed ID: 34006655
    [No Abstract]   [Full Text] [Related]  

  • 16. Viruses to the rescue-Use of bacteriophage to treat resistant pulmonary infections.
    Toporek A; Lechtzin N
    Cell; 2022 May; 185(11):1807-1808. PubMed ID: 35623325
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Degiacomi G; Sammartino JC; Chiarelli LR; Riabova O; Makarov V; Pasca MR
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative and Experimental Therapies of
    Meir M; Barkan D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948001
    [No Abstract]   [Full Text] [Related]  

  • 19. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection.
    Dedrick RM; Freeman KG; Nguyen JA; Bahadirli-Talbott A; Smith BE; Wu AE; Ong AS; Lin CT; Ruppel LC; Parrish NM; Hatfull GF; Cohen KA
    Nat Med; 2021 Aug; 27(8):1357-1361. PubMed ID: 34239133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.